Federal contractor · public award history
VENATORX PHARMACEUTICALS INC
Parent: VENATORX PHARMACEUTICALS INC Unique Entity Identifier (UEI)MBBKNBU5DCC6
- Awards we know about
- 4
- Typical size
- $60.36M
- Middle of their public awards
- Dollars on those awards
- $252.95M
Most of their awards we can see fall roughly between $42.69M and $87.20M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Dec 8, 2026
- Activation date
- Dec 10, 2025
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Product and Service Codes (SAM)
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (4)
Industries & product codes
Award history
- Department of Health and Human Services$48.58MSep 23, 2025Procurement Instrument Identifier (PIID)HHSN272201600029CNorth American Industry Classification System (NAICS)541711Health R&D Services; Health Care Services; Applied ResearchAN12Contract awardUSAspending ↗
IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
- Department of Health and Human Services$132.37MSep 3, 2025Procurement Instrument Identifier (PIID)75A50119C00007Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
VENATORX PHARMACEUTICALS, INC.
- Department of Health and Human Services$25.04MJul 31, 2025Procurement Instrument Identifier (PIID)75N93020C00016Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715Health R&D Services; Health Care Services; Applied ResearchAN12Contract awardUSAspending ↗
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
- Department of Health and Human Services$72.14MNov 25, 2024Procurement Instrument Identifier (PIID)75A50122C00080Research and Development in Biotechnology (except Nanobiotechnology)541714Drugs And Biologicals6505Contract awardUSAspending ↗
VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.